AIA Investment Management’s Dr. Reddy's Laboratories RDY Stock Holding History

AIA Investment Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$182K	Buy	+13,075	New	+$156K	0.04%	179

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

AIA Investment Management's RDY Position: Q3 2020 in Review

AIA Investment Management opened a new position in Dr. Reddy's Laboratories (RDY) in Q3 2020: 13,075 shares worth $182K. The stake represents 0.04% of the portfolio and ranks #179 among its holdings.

186 funds tracked by Wall St. Rank hold RDY as of Q3 2020.

AIA Investment Management held 13,075 shares of Dr. Reddy's Laboratories worth $182K as of Q3 2020.
Dr. Reddy's Laboratories was a new AIA Investment Management position in Q3 2020.
Dr. Reddy's Laboratories made up 0.04% of AIA Investment Management's portfolio in Q3 2020, its #179 holding.
186 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2020.

Based on AIA Investment Management's 13F filing for Q3 2020, filed 16 Nov 2020.